A 6 Month Safety Extension Study of MBGS205

Completed · Phase 2

Conditions studied: Hypogonadotropic Hypogonadism

In brief

Phase IIb, multicentre, double-blind, randomised, placebo-controlled parallel-group 36-week study evaluating safety and efficacy of BGS649 in male obese subjects with hypogonadotropic hypogonadism (HH)

Key facts

Study ID

NCT02908074

Run by

Mereo BioPharma

People needed

143

Starts

2016-11-15

Expected to finish

2018-11-21

Last updated by the study team

2023-05-18

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Participating in Study MBGS205 and completion of the 24 week treatment period without meeting any discontinuation criteria of Study MBGS205
• In opinion of the investigator has been compliant with the requirements of the Study MBGS205 protocol.

You may not qualify if…

• Meeting any of the discontinuation criteria of initial Study MBGS205

Where it is running

• Mereo Research Site — Mobile, Alabama, United States
• Mereo Research Site — Chandler, Arizona, United States
• Mereo Research Site — Phoenix, Arizona, United States
• Mereo Research Site — Scottsdale, Arizona, United States
• Mereo Research Site — Anaheim, California, United States
• Mereo Research Site — Greenbrae, California, United States
• Mereo Research Site — Lincoln, California, United States
• Mereo Research Site — Los Angeles, California, United States
• Mereo Research Site — San Diego, California, United States
• Mereo Research Site — Bradenton, Florida, United States
• Mereo Research Site — DeLand, Florida, United States
• Mereo Research Site — Fort Myers, Florida, United States
• Mereo Research Site — Hialeah, Florida, United States
• Mereo Research Site — St. Petersburg, Florida, United States
• Mereo Research Site — Meridian, Idaho, United States
• Mereo Research Site — Evansville, Indiana, United States
• Mereo Research Site — Marrero, Louisiana, United States
• Mereo Research Site — Elkridge, Maryland, United States
• Mereo Research Site — Henderson, Nevada, United States
• Mereo Research Site — Las Vegas, Nevada, United States
• Mereo Research Site — Albany, New York, United States
• Mereo Research Site — Garden City, New York, United States
• Mereo Research Site — Great Neck, New York, United States
• Mereo Research Site — New York, New York, United States
• Mereo Research Site — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.